| Trial registration number
|
NCT05092516 |
Full text link
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05092516
|
First author
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Hamdi Eryilmaz, Ph.D.
|
Contact
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
hamdi.eryilmaz@mgh.harvard.edu
|
Registration date
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
2021-10-25
|
Recruitment status
Last imported at : Sept. 2, 2022, 10 p.m.
Source : ClinicalTrials.gov
|
Recruiting
|
Study design
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Long covid
|
Inclusion criteria
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
- ability to provide informed consent
- a diagnosis of pasc as indicated by past covid-19 infection, and persistent symptoms,
including 'brain fog', confusion, short-term memory deficits, trouble concentrating,
delirium, difficulties in multitasking.
|
Exclusion criteria
Last imported at : April 12, 2022, 11 p.m.
Source : ClinicalTrials.gov
|
history of epilepsy
metallic implants in the head and neck,
brain stimulators
pacemakers
pregnancy
active substance dependence (except for tobacco)
premorbid major neurological illness
severe mental illness (e.g., bipolar disorder, schizophrenia)
attention deficit hyperactivity disorder
|
Number of arms
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Massachusetts General Hospital
|
Inclusion age min
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
65
|
Countries
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
United States
|
Type of patients
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Patients recovered from covid
|
Severity scale
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
40
|
primary outcome
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
Change in EEG P300 event-related potential;Change in inhibitory control;Change in processing speed
|
Notes
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Oct. 26, 2021, 11 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1310, "treatment_name": "Transcranial direct-current stimulation", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|